Literature DB >> 15500492

Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization.

Mohammad Golparvar1, Mahmood Saghaei, Parvin Sajedi, Seid Sajad Razavi.   

Abstract

BACKGROUND: Paradoxical reactions to benzodiazepines include restlessness, violent behavior, physical assault, act of self-injury and need for restraints. These may occur at variable times after administration. This study was designed to determine the incidence of paradoxical reactions following intravenous midazolam premedication in pediatric patients and to compare the efficacy of extra doses of midazolam with low-dose intravenous ketamine to rapidly tranquillize them.
METHODS: A total of 706 ASA I, II children scheduled for elective surgery were given intravenous midazolam premedication. Children who developed a paradoxical reaction were randomly divided into three equal groups to receive: (i) extra midazolam, (ii) ketamine, or (iii) placebo as the test drug for treatment of paradoxical reaction. Ease of rapid tranquillization and need for a rescue tranquillizer (i.e. ketamine; irrespective of patient group) were compared among the three groups.
RESULTS: Twenty-four (3.4%) children developed paradoxical reaction after midazolam premedication. Those who received ketamine as the test drug responded rapidly to ketamine. But the responses of the other two groups to their test drug were poor and the majority of them required ketamine as rescue tranquillizer (six in midazolam, seven in placebo, but no patient in the ketamine group; P < 0.05).
CONCLUSIONS: The results of this study demonstrate that ketamine is an effective drug for the treatment of paradoxical reaction following intravenous midazolam premedication. The exact mechanisms of these reactions and how it is aborted by ketamine are not clear.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500492     DOI: 10.1111/j.1460-9592.2004.01349.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  27 in total

1.  High-dose midazolam therapy for refractory status epilepticus in children.

Authors:  Gavin Morrison; Elizabeth Gibbons; William Patrick Whitehouse
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

2.  Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient.

Authors:  Julie K Drobish; Max B Kelz; Patricia M DiPuppo; Scott D Cook-Sather
Journal:  A A Case Rep       Date:  2015-06-01

Review 3.  [Premedication with midazolam: indispensable and good?].

Authors:  A Machotta; G Schneider
Journal:  Anaesthesist       Date:  2013-03       Impact factor: 1.041

4.  Deep sedation in pediatric imaging: efficacy and safety of intravenous chlorpromazine.

Authors:  C Heng Vong; A Bajard; P Thiesse; E Bouffet; H Seban; P Marec Bérard
Journal:  Pediatr Radiol       Date:  2012-01-13

Review 5.  Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.

Authors:  Narjeet Khurmi; Perene Patel; Molly Kraus; Terrence Trentman
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

6.  The effect of midazolam dose and age on the paradoxical midazolam reaction in Korean pediatric patients.

Authors:  Young Hee Shin; Myung Hee Kim; Jung Jin Lee; Soo Joo Choi; Mi Sook Gwak; Ae Ryoung Lee; Mi Na Park; Hyo Sung Joo; Jung Hee Choi
Journal:  Korean J Anesthesiol       Date:  2013-07-19

Review 7.  Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation.

Authors:  Tong J Gan
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Sedation or inhalant anesthesia before euthanasia with CO2 does not reduce behavioral or physiologic signs of pain and stress in mice.

Authors:  Helen Valentine; Wendy O Williams; Kirk J Maurer
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-01       Impact factor: 1.232

9.  Pain management following myringotomy and tube placement: intranasal dexmedetomidine versus intranasal fentanyl.

Authors:  Elisabeth Dewhirst; Gina Fedel; Vidya Raman; Julie Rice; N'Diris Barry; Kris R Jatana; Charles Elmaraghy; Meredith Merz; Joseph D Tobias
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-04-16       Impact factor: 1.675

10.  A comparison of fospropofol to midazolam for moderate sedation during outpatient dental procedures.

Authors:  Philip Yen; Simon Prior; Cara Riley; William Johnston; Megann Smiley; Sarat Thikkurissy
Journal:  Anesth Prog       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.